Beijing Bohui Innovation Technology Co Ltd
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fl… Read more
Beijing Bohui Innovation Technology Co Ltd (300318) - Net Assets
Latest net assets as of September 2025: CN¥2.29 Billion CNY
Based on the latest financial reports, Beijing Bohui Innovation Technology Co Ltd (300318) has net assets worth CN¥2.29 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.33 Billion) and total liabilities (CN¥2.04 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.29 Billion |
| % of Total Assets | 52.9% |
| Annual Growth Rate | 21.31% |
| 5-Year Change | 63.26% |
| 10-Year Change | 83.06% |
| Growth Volatility | 48.73 |
Beijing Bohui Innovation Technology Co Ltd - Net Assets Trend (2004–2024)
This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Beijing Bohui Innovation Technology Co Ltd (2004–2024)
The table below shows the annual net assets of Beijing Bohui Innovation Technology Co Ltd from 2004 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.35 Billion | +0.37% |
| 2023-12-31 | CN¥2.34 Billion | +0.72% |
| 2022-12-31 | CN¥2.32 Billion | +149.14% |
| 2021-12-31 | CN¥932.75 Million | -35.18% |
| 2020-12-31 | CN¥1.44 Billion | +36.76% |
| 2019-12-31 | CN¥1.05 Billion | -15.42% |
| 2018-12-31 | CN¥1.24 Billion | -22.91% |
| 2017-12-31 | CN¥1.61 Billion | +5.85% |
| 2016-12-31 | CN¥1.52 Billion | +18.79% |
| 2015-12-31 | CN¥1.28 Billion | +76.62% |
| 2014-12-31 | CN¥726.57 Million | +3.42% |
| 2013-12-31 | CN¥702.55 Million | +6.61% |
| 2012-12-31 | CN¥658.98 Million | +164.10% |
| 2011-12-31 | CN¥249.52 Million | +21.12% |
| 2010-12-31 | CN¥206.00 Million | +21.45% |
| 2009-12-31 | CN¥169.62 Million | +24.76% |
| 2008-12-31 | CN¥135.96 Million | +36.98% |
| 2007-12-31 | CN¥99.25 Million | +28.97% |
| 2006-12-31 | CN¥76.95 Million | +20.73% |
| 2005-12-31 | CN¥63.74 Million | +29.24% |
| 2004-12-31 | CN¥49.32 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Beijing Bohui Innovation Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1676.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥816.90 Million | 59.25% |
| Other Comprehensive Income | CN¥12.52 Million | 0.91% |
| Other Components | CN¥748.55 Million | 54.29% |
| Total Equity | CN¥1.38 Billion | 100.00% |
Beijing Bohui Innovation Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Beijing Bohui Innovation Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dezhou United Petroleum Technology Co.Ltd.
SHE:301158
|
$266.67 Million |
|
AnHui Annada Titanium Industry Co Ltd
SHE:002136
|
$266.69 Million |
|
Cytodyn Inc
OTCQB:CYDY
|
$266.75 Million |
|
Yindu Kitchen Equipment Co Ltd
SHG:603277
|
$266.77 Million |
|
ShenZhen Zero-Seven Co Ltd
SHE:000007
|
$266.60 Million |
|
Qinhuangdao Tianqin Equipment Manufacturing Co.Ltd.
SHE:300922
|
$266.55 Million |
|
Flughafen Wien AG
LSE:0RHU
|
$266.55 Million |
|
Clenergy Xiamen Technology Co Ltd
SHG:603628
|
$266.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beijing Bohui Innovation Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,369,538,542 to 1,378,686,990, a change of 9,148,448 (0.7%).
- Net income of 9,245,978 contributed positively to equity growth.
- Dividend payments of 32,659,974 reduced retained earnings.
- Other comprehensive income increased equity by 9,961,697.
- Other factors increased equity by 22,600,747.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥9.25 Million | +0.67% |
| Dividends Paid | CN¥32.66 Million | -2.37% |
| Other Comprehensive Income | CN¥9.96 Million | +0.72% |
| Other Changes | CN¥22.60 Million | +1.64% |
| Total Change | CN¥- | 0.67% |
Book Value vs Market Value Analysis
This analysis compares Beijing Bohui Innovation Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.68x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 38.90x to 3.68x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | CN¥0.16 | CN¥6.21 | x |
| 2005-12-31 | CN¥0.21 | CN¥6.21 | x |
| 2006-12-31 | CN¥0.25 | CN¥6.21 | x |
| 2007-12-31 | CN¥0.32 | CN¥6.21 | x |
| 2008-12-31 | CN¥0.28 | CN¥6.21 | x |
| 2009-12-31 | CN¥0.33 | CN¥6.21 | x |
| 2010-12-31 | CN¥0.40 | CN¥6.21 | x |
| 2011-12-31 | CN¥0.49 | CN¥6.21 | x |
| 2012-12-31 | CN¥1.79 | CN¥6.21 | x |
| 2013-12-31 | CN¥1.07 | CN¥6.21 | x |
| 2014-12-31 | CN¥0.99 | CN¥6.21 | x |
| 2015-12-31 | CN¥1.71 | CN¥6.21 | x |
| 2016-12-31 | CN¥1.74 | CN¥6.21 | x |
| 2017-12-31 | CN¥1.81 | CN¥6.21 | x |
| 2018-12-31 | CN¥1.43 | CN¥6.21 | x |
| 2019-12-31 | CN¥1.26 | CN¥6.21 | x |
| 2020-12-31 | CN¥1.59 | CN¥6.21 | x |
| 2021-12-31 | CN¥1.19 | CN¥6.21 | x |
| 2022-12-31 | CN¥1.71 | CN¥6.21 | x |
| 2023-12-31 | CN¥1.68 | CN¥6.21 | x |
| 2024-12-31 | CN¥1.69 | CN¥6.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beijing Bohui Innovation Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.67%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.09%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 2.99x
- Recent ROE (0.67%) is below the historical average (7.78%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 27.96% | 56.26% | 0.42x | 1.17x | CN¥8.86 Million |
| 2005 | 21.84% | 53.79% | 0.34x | 1.19x | CN¥7.54 Million |
| 2006 | 16.83% | 44.11% | 0.36x | 1.05x | CN¥5.26 Million |
| 2007 | 22.47% | 56.60% | 0.37x | 1.07x | CN¥12.37 Million |
| 2008 | 29.60% | 77.44% | 0.35x | 1.08x | CN¥26.39 Million |
| 2009 | 16.05% | 40.75% | 0.36x | 1.10x | CN¥9.76 Million |
| 2010 | 17.16% | 43.04% | 0.37x | 1.09x | CN¥14.07 Million |
| 2011 | 18.54% | 45.63% | 0.37x | 1.08x | CN¥20.63 Million |
| 2012 | 7.81% | 44.79% | 0.16x | 1.07x | CN¥-14.29 Million |
| 2013 | 7.78% | 50.77% | 0.14x | 1.08x | CN¥-15.49 Million |
| 2014 | 5.27% | 37.77% | 0.13x | 1.10x | CN¥-34.27 Million |
| 2015 | 0.86% | 4.42% | 0.13x | 1.49x | CN¥-126.96 Million |
| 2016 | 1.66% | 5.84% | 0.19x | 1.48x | CN¥-118.34 Million |
| 2017 | 2.64% | 8.76% | 0.16x | 1.86x | CN¥-108.57 Million |
| 2018 | 5.92% | 11.16% | 0.23x | 2.31x | CN¥-47.89 Million |
| 2019 | 0.25% | 0.40% | 0.23x | 2.61x | CN¥-100.60 Million |
| 2020 | 0.58% | 1.02% | 0.20x | 2.86x | CN¥-122.49 Million |
| 2021 | -33.05% | -45.08% | 0.19x | 3.79x | CN¥-419.65 Million |
| 2022 | -5.62% | -9.84% | 0.20x | 2.80x | CN¥-217.68 Million |
| 2023 | -1.82% | -2.38% | 0.27x | 2.87x | CN¥-161.88 Million |
| 2024 | 0.67% | 1.09% | 0.21x | 2.99x | CN¥-128.62 Million |
Industry Comparison
This section compares Beijing Bohui Innovation Technology Co Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,043,310,248
- Average return on equity (ROE) among peers: 14.20%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beijing Bohui Innovation Technology Co Ltd (300318) | CN¥2.29 Billion | 27.96% | 0.89x | $266.67 Million |
| Shenzhen CAU Technology Co Ltd (000004) | $124.02 Million | 4.50% | 1.13x | $80.66 Million |
| Pacific Shuanglin Bio pharmacy Co Ltd (000403) | $525.49 Million | 14.76% | 1.41x | $1.02 Billion |
| Nanhua Bio Medicine Co Ltd (000504) | $174.34 Million | 36.11% | 1.61x | $288.51 Million |
| Jiangsu Sihuan Bioengineering Co Ltd (000518) | $642.80 Million | -4.58% | 0.44x | $244.62 Million |
| Chengzhi Shareholding Co Ltd (000990) | $1.69 Billion | 3.06% | 0.97x | $850.04 Million |
| Hualan Biological EngineeringInc (002007) | $1.86 Billion | 32.78% | 0.08x | $2.00 Billion |
| Da An Gene Co Ltd of Sun Yat-Sen University (002030) | $2.09 Billion | 4.42% | 0.71x | $784.18 Million |
| Shanghai RAAS Blood Products Co Ltd Class A (002252) | $831.21 Million | 22.32% | 0.12x | $3.76 Billion |
| Baolingbao Biology Co Ltd (002286) | $2.04 Billion | 5.44% | 0.31x | $398.99 Million |
| Tibet Cheezheng Tibetan Medicine Co Ltd (002287) | $456.61 Million | 23.20% | 0.29x | $347.95 Million |